Clinical Services

MentisCura’s innovative, functional use of electroencephalogram (EEG) technology is a non-invasive, affordable and accessible diagnostic aid.

Through a normal web browser, clinicians can access a powerful state of the art differential diagnostic service for CNS diseases. An expert functional report with the analysis is delivered directly to clinicians and medical monitors.

SIGLA™ and KALTA™ are CE marked diagnostic aids, based on advanced, proprietary EEG-biomarker technology platform that accurately maps changes in electrophysiology to specific disease pathologies, through correlation with the world´s most comprehensive proprietary EEG database for dementia and ADHD.


In 2012 MentisCura’s launched the world’s first fully-automated system to use a five minute EEG recording to provide a fast, accurate and reliable assessment of the likelihood that a patient is suffering from a neurological disorder

MentisCura’s service capitalizes on a decade and €20m of capital and in-kind contribution invested in the development of uniquely powerful, proprietary EEG biomarkers of neurodegenerative disorders

Learn more


SIGLA from MentisCura provides what is essentially the first EEG biomarker for dementia. Using EEG, a widely available and simple technology, clinicians can access individual, evidence-based reports containing actionable information.

Learn more


An electrophysiological biomarker, based on a decade of research and development, KATLA™ represents a new generation of computerised diagnostic aids for ADHD in children. Advanced computing methodologies are injecting new life into traditional EEG recording techniques, marrying a simple and familiar device with highly sophisticated software to open a new chapter in CNS diagnostics.

Learn more